
NEWS SUMMARY REPORT
Topic: corona virus
================================================================================

Report Date: November 23, 2025
Report Time: 02:32 PM

EXECUTIVE SUMMARY
--------------------------------------------------------------------------------

Here is a brief, cohesive executive summary of the provided news summaries,
focusing on the most important points related to the coronavirus:
The global response to the COVID-19 pandemic continues to evolve, with various
institutions and researchers working tirelessly to combat the crisis. On the
research front, Texas Biomed and the Institut Pasteur have made significant
contributions, including the development of variant-specific COVID-19
treatments and advancements in tracking the spread of the virus. Texas Biomed's
innovative approach, such as using "reporter genes" to make the virus glow in
the dark, enables real-time monitoring and has the potential to greatly enhance
our understanding of the pandemic. Meanwhile, the Institut Pasteur has
initiated several research projects to better comprehend the SARS-CoV-2 virus
and improve treatment options. In academic settings, institutions like Duke
University have established rigorous protocols for researchers working with
COVID-19 specimens, ensuring a safe and controlled environment for scientific
inquiry. It's worth noting that these efforts are not directly related to
recent tax relief measures, such as the IRS's new guidance on deducting
qualified overtime compensation, which will take effect in 2025. Overall, the
collective efforts of these researchers and institutions are crucial to the
global fight against COVID-19, and their contributions will likely play a
significant role in shaping our response to the pandemic in the years to come.


ARTICLE SUMMARIES
--------------------------------------------------------------------------------

1. COVID-19 News Updates

The Internal Revenue Service (IRS) has released guidance allowing employees to
deduct qualified overtime compensation from their federally taxable income
starting in 2025. This policy aims to provide tax relief for certain overtime
payments. The new guidance, also referred to as "no tax on overtime," will take
effect next year. Employees can visit the IRS website for more information on
the new policy and how to claim the deduction.

Source: https://www.gfoa.org/covid-19-news-updates

--------------------------------------------------------------------------------

2. COVID-19 News Updates

Texas Biomed has been actively involved in COVID-19 research, with experts
appearing in various news outlets to discuss developments in vaccine creation,
variant tracking, and treatment options. The institute has been working on
creating variant-specific COVID-19 treatments and studying the effectiveness of
vaccines and therapies against new variants, including Omicron. Researchers at
Texas Biomed have also made advancements in tracking the spread of COVID-19,
including the use of "reporter genes" to make the virus glow in the dark,
allowing for real-time monitoring. These efforts aim to contribute to the
global understanding and fight against the pandemic.

Source: https://www.txbiomed.org/coronavirus/covid-19-news-updates/

--------------------------------------------------------------------------------

3. Our Sars-Cov-2 research projects

The Institut Pasteur has intensified its efforts since 2020 to combat the
COVID-19 crisis. The institution's scientific focus is on protecting public
health through epidemiology and modeling expertise, as well as improving
treatment options for individuals. To achieve this, the Institut Pasteur has
initiated several research projects to better understand the SARS-CoV-2 virus
and develop effective solutions. These efforts aim to contribute to the global
response to the pandemic.

Source: https://www.pasteur.fr/en/home/all-sars-cov-2-covid-19-institut-pasteur/our-sars-cov-2-research-projects

--------------------------------------------------------------------------------

4. COVID-19/SARS-CoV-2 Research

Researchers at Duke University must register and receive approval from the
Dean's Office for all studies involving COVID-19 specimens, including patient
samples and animal specimens. Registration and approval can be done through the
COVID Research Dashboard on the university's website. As part of the
registration process, researchers must submit a Biosafety Level 2 (BSL2)
Standard Operating Procedure (SOP) and review the SARS-CoV-2 Biosafety
Guidelines. The Office of Environmental Health and Safety's Biological Safety
Division is available for guidance and can be contacted at 919-684-8822.

Source: https://www.safety.duke.edu/biological-safety/covid-19sars-cov-2-research

--------------------------------------------------------------------------------

END OF REPORT
================================================================================
